1 Product identity
Ingredient risk
2 ingredients to use with caution

B6 Phosphate

BrandBiotics Research Corporation→Other Combinations Tablet or Pill 7 ingredients 2 caution DSLD #21474
Net contents: 100 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-08-23
2 Ingredients (7)
IngredientGroupSafety
Vitamin B6Vitamin B6 (unspecified)Use with Caution
Superoxide DismutaseSuperoxide Dismutase—
CatalaseCatalase—
CelluloseCellulose—
Stearic AcidStearic Acid—
Magnesium StearateMagnesium stearateUse with Caution
Food GlazeCoating—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Vitamin B6 — Sensory neuropathy from chronic high-dose B6 (>200 mg/day) — presents as numbness, ataxia. Can be irreversible. Often self-prescribed by patients…
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Vitamin B6 — Use with Caution
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
GLA — Limited Evidence
⚠ May lower seizure threshold
⚠ Borage oil: hepatotoxic unless PA-free
4 Label claims
• All Other
5 Data source
DSLD ID21474
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-08-23
6 More from Biotics Research Corporation
View Biotics Research Corporation Safety Scorecard → 240 products
5-HTP7-Keto-ZymeA.D.P.Acetyl-L-CarnitineADB5-PlusADHS
7 Cite this page
Vancouver
Pkhakadze G. B6 Phosphate — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 24]. Available from: https://supplement.ge/products/b6-phosphate-21474/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG